Skip to main content

Table 2 ADC, tumor SUVmax and SUV ratio of post TACE viable and nonviable HCC

From: The role of functional imaging; DWI, ADC and 18F-FDG PET/CT in the evaluation of HCC treatment response after transarterial chemoembolization

  Viable HCC Nonviable HCC Value* p value Sig.
Mean ± SD Range Mean ± SD Range
ADC (× 10−3 mm2/s) 1.06 ± 0.24 0.58–1.39 1.55 ± 0.33 1.23–2.08 4.677 < 0.001 S
Tumor SUVmax 4.26 ± 0.15 2.4–7.9 2.46 ± 1.05 1.1–3.9 − 3.966 < 0.001 S
SUV ratio 1.42 ± 0.54 1–2.11 0.92 ± 0.26 0.54–1.31 − 3.028 0.005 S
  1. S significant
  2. *Independent sample t test